OBIO
Orchestra BioMed Holdings Inc.
NASDAQ: OBIO · HEALTHCARE · BIOTECHNOLOGY
$3.80
-2.56% today
Updated 2026-04-29
Market cap
$239.94M
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$2 – $5
Volume
0.2M
Orchestra BioMed Holdings Inc. (OBIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-157.40%
Operating margin
21.80%
ROE
-109.40%
ROA
-33.90%
Debt/equity
0.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $5.70M | $-21.36M | 97.46% | -328.81% | -374.45% |
| 2021 | $-782000.00 | $-23.01M | 125.45% | 2,787.60% | 2,942.97% |
| 2022 | $3.53M | $-33.61M | 90.89% | -924.34% | -951.26% |
| 2023 | $2.76M | $-49.12M | 93.26% | -1,866.16% | -1,779.71% |
| 2024 | $2.64M | $-61.02M | 92.27% | -2,437.49% | -2,313.27% |
| 2025 | $33.48M | $-52.95M | 99.43% | -154.73% | -158.16% |